Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc. (NYSE: A) is a global company in analytical and clinical laboratory technologies, and its news flow reflects activity across life sciences, diagnostics, and applied markets. Company announcements highlight how Agilent’s instruments, software, services, and expertise are used to help customers bring great science to life, as well as how it manages its financial performance and corporate governance.
On this page, readers can follow Agilent news related to earnings results, product introductions, regulatory-focused solutions, capital allocation, and investor events. Recent releases include quarterly and full-year financial results, with details on revenue, net income, and segment performance for the Life Sciences and Diagnostics Markets Group, the Agilent CrossLab Group, and the Applied Markets Group. These updates often include management commentary on business conditions and outlook.
Agilent’s news also covers product and technology developments. For example, the company has announced 21 CFR Part 11 compliance software for the xCELLigence RTCA eSight system, designed to support use in GMP-regulated manufacturing and quality control environments by adding secure user authentication, electronic signatures, and audit trails. Another announcement introduced Agilent Altura Ultra Inert HPLC Columns, described as high performance liquid chromatography columns suited for biotherapeutics applications such as peptide GLP-1 and oligonucleotide therapeutic development and quality control.
Investors and analysts can also find updates on capital markets activities, such as cash dividend declarations on Agilent’s common stock, and notices of participation in healthcare and investor conferences. Governance-related news, including leadership transitions and executive appointments, is communicated through press releases and related SEC filings. Bookmarking this page allows users to review Agilent’s ongoing communications about its operations, technologies, financial performance, and corporate developments in one place.
Agilent Technologies (NYSE: A) has appointed August Specht, Ph.D. as its new Chief Technology Officer, effective June 9, 2025. Specht joins Agilent from Thermo Fisher Scientific, where he served as vice president of Global R&D for the Chromatography and Mass Spectrometry Division. With over 25 years of experience in analytical instruments, software, and consumables development, Specht brings extensive expertise in R&D, product management, strategy, and business development from his roles at Thermo Fisher and Varian Instruments.
Specht holds a B.S. in Chemistry from Queen's University, a Ph.D. in Analytical Chemistry from the University of British Columbia, and an MBA from UC Berkeley. Agilent, a global leader in analytical and clinical laboratory technologies, reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.
Agilent Technologies (NYSE: A) has announced significant enhancements to its 8850 Gas Chromatograph (GC), now featuring compatibility with single and triple quadrupole mass spectrometry (MS) systems. The upgraded system stands out as one of the fastest and smallest benchtop GC/MS available, delivering up to 300°C/min oven ramp rates and fast cool-down times.
Key improvements include increased temperature range, compatibility with CTC PAL3 Series 2 Autosampler Systems, Multi-Mode Inlet (MMI), and backflush capabilities. The system achieves 45% less power usage compared to other benchtop GC systems, supporting sustainability goals while maintaining high performance. When integrated with 5977C, 7000E, or 7010D MS systems, it provides enhanced molecular identification and quantification capabilities for chemicals, energy, food, environmental, and forensic laboratories.
Agilent Technologies (NYSE: A) has declared a quarterly dividend of 24.8 cents per share of common stock. The dividend will be paid on July 23, 2025, to shareholders of record as of July 1, 2025. The company notes that future dividend amounts and timing will be subject to board approval.
Agilent Technologies (NYSE: A) has announced two significant additions to its Board of Directors: Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, effective May 21, 2025. Soriot brings extensive pharmaceutical industry experience as AstraZeneca's CEO since 2012, while Gawlik Brown contributes substantial financial and strategic expertise from her roles at Perrigo Company and Amgen. The appointments coincide with Agilent's three-year Ignite Transformation initiative.
Simultaneously, Heidi Kunz is retiring from the Board after more than 20 years of service, having joined at the company's inception in 2000. Agilent, which generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide, continues its commitment to balanced Board refreshment.
FAQ
What is the current stock price of Agilent Technologies (A)?
What is the market cap of Agilent Technologies (A)?
